Search Results - "Gabitass, R. F."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC)

    Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC) by Gabitass, R. F., Annels, N. E., Crawshaw, J., Pandha, H. S., Middleton, G. W.

    Published in Journal of clinical oncology (20-05-2011)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Prevalence and prognostic significance of myeloid-derived suppressor cells and regulatory T cells in pancreatic and esophagogastric cancer

    Prevalence and prognostic significance of myeloid-derived suppressor cells and regulatory T cells in pancreatic and esophagogastric cancer by Gabitass, R. F., Annels, N. E., Pandha, H. S., Middleton, G. W.

    Published in Journal of clinical oncology (20-05-2010)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: